Current Residents

Brian Foster

I received my Doctorate of Pharmacy from the University of Rhode Island College of Pharmacy in 2019. I practiced as a pharmacist for one year at Kent Hospital in Warwick, RI in the inpatient pharmacy as well as the outpatient anticoagulation clinic before returning to Pennsylvania to complete my PGY1 Pharmacy Practice Residency at Penn Medicine Lancaster General Health in 2021. My current professional interests include cardiology, chronic disease management, and hematology/oncology. In my free time I enjoy cooking, trying new restaurants, traveling, sports/fitness, and finding new ways to be active.

Major Research Project: Evaluation of Osteoporosis Treatment in Patients Treated with Raloxifene
Medication Use Evaluation: Optimizing Medication Therapy and Outcomes for Patients with Diabetes and Heart Failure
Pharmacotherapy Grand Rounds: To be determined

Graduate Residents

Carrie Clutter

Pharmacy School: West Virginia University School of Pharmacy
PGY1 Residency: Pharmacy Practice Residency, Lancaster General Health
Position upon completion of program: Ambulatory Care Clinical Pharmacist
Location: West Virginia University Medicine
Major Research Project: Role of the pharmacist in the transition of care between an endocrinology specialist medical practice back to primary care
Medication Use Evaluation: Evaluation of the usage of inhaled corticosteroids in patients with chronic obstructive pulmonary disease in the primary care setting
Grand Rounds: Latent Autoimmune Diabetes in Adults (LADA): Is Insulin the Only Option?

Mara Wilson

Pharmacy School: Wilkes University, Nesbitt School of Pharmacy
PGY1 Residency: Pharmacy Practice Residency, Lancaster General Health
Position upon completion of program: Ambulatory Care Clinical Pharmacist
Location: Lancaster General Health
Major Research Project: Social determinants of glycemic control
Medication Use Evaluation: Identification of patients on anticoagulation who are eligible to transition from traditional warfarin therapy to direct oral anticoagulant therapy
Grand Rounds: Analysis of Cardiovascular Outcomes with Glucagon Like Peptide-1 Receptor Agonists

Share This Page: